Table 1 Patient and treatment characteristics
Characteristic | |
|---|---|
Age, years, median (range) | 77 (39–93) |
Sex, n (%) | |
Male | 61 (64) |
Female | 35 (36) |
Operability, n (%) | |
Operable | 25 (26) |
Inoperable | 71 (74) |
Histological type, n (%) | |
Adenocarcinoma | 15 (16) |
Squamous cell carcinoma | 4 (4) |
Not identified | 77 (80) |
T factor, n (%) | |
T1a | 14 (15) |
T1b | 47 (49) |
T1c | 30 (31) |
T2a | 5 (5) |
Dose prescription to GTV, n (%) | |
54 Gy in 3 fractions | 91 (95) |
60 Gy in 3 fractions | 5 (5) |
Prescribed Isodose line, %, median (range) | 76 (60–97) |
V20Gy, %, median (range) | 2.4 (0.2–11.0) |
GTV D99, %, median (range) | 101.4 (82.7–118.7) |
PTV D95, %, median (range)) | 95.6 (79.8–112.9) |